Glycopyrrolate Injection recall: Labeling Error
Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) 25 x 2 mL Single Dose Vials Rx Only, Manufactured for: Accord Healthcare, Inc. Durham, NC 27703…
Why was Glycopyrrolate Injection recalled?
Labeling; Label Mix-up; correctly labeled 2 mL vials were packaged into blister strips labeled for 1 mL vials
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot: M2013645 Exp. Aug. 2022
- Product
- Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) 25 x 2 mL Single Dose Vials Rx Only, Manufactured for: Accord Healthcare, Inc. Durham, NC 27703…
- Recalling firm
- Accord Healthcare, Inc.
- Quantity
- 502 cartons
- Distribution
- Nationwide
- Recall date
- February 17, 2021
- Classification
- Class III
- Status
- Terminated
- Agency
- FDA (drug)